A hadron therapy center for the treatment of cancer is being created at Moscow State University. Hitachi equipment will be delivered there

On February 24, 2021, the holding Schwab"," the Development Fund MSU and the Management Company of the university's innovation center signed an agreement on the creation of a hadron therapy center. cancer The project will be implemented as part of the innovative Scientific and Technological Center of Moscow State University named after M.V. Lomonosov. ""Sparrow Hills

The center of oncotherapy will conduct research in the field of biology, medicine, physics, develop new medical and engineering-physical solutions, which will then be replicated in Russia and abroad. Students - medical physicists, radiologists and other scarce specialists will be trained here.

The technological partner of Schwabe will be the Japanese industrial group Hitachi. According to the creators of the cancer clinic, the company will provide the transfer of proven medical technologies that have quality certificates for sanitary services in Japan, the USA, EU countries and other territories.

Moscow State University creates a hadron therapy center for the treatment of cancer using Hitachi equipment

For hadron therapy, special accelerators are used that form a narrow beam of protons/ions, which locally acts on the tumor without affecting neighboring organs. The method makes it possible to cure the disease of areas of the body located close to critical radiosensitive organs, as well as to irradiate the foci of pathology of an extremely small size. Another important advantage of the new technology is a significant reduction in the course of exposure.

We believe that the hadron therapy center in the valley should become in some way a center of collective use, where these institutions will be able to refer patients for treatment. To best realize the common goals of this partnership, we are ready to use all the available resources of leading enterprises, research institutes and design bureaus of the holding, "said Alexey Patrikeev, General Director of Schwabe, member of the Bureau of the Union of Machine Builders of Russia.

It is expected that the project of the scientific and clinical center for hadron therapy will undergo the process of coordination with federal executive authorities, the Moscow City Hall and investors in 2021.^[1]

Notes